(Q42482850)

English

Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor alpha for the treatment of malignant gliomas

scientific article published on January 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor alpha for the treatment of malignant gliomas (English)

1 reference

Europe PubMed Central

1 November 2017

author name string

M Tada

1

1 reference

Europe PubMed Central

1 November 2017

Y Sawamura

2

1 reference

Europe PubMed Central

1 November 2017

S Sakuma

3

1 reference

Europe PubMed Central

1 November 2017

K Suzuki

4

1 reference

Europe PubMed Central

1 November 2017

H Ohta

5

1 reference

Europe PubMed Central

1 November 2017

T Aida

6

1 reference

Europe PubMed Central

1 November 2017

H Abe

7

1 reference

Europe PubMed Central

1 November 2017

publication date

1 January 1993

1 reference

Europe PubMed Central

1 November 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

1 November 2017

36

1 reference

Europe PubMed Central

1 November 2017

251-259

1 reference

Europe PubMed Central

1 November 2017

4

1 reference

Europe PubMed Central

1 November 2017

https://scigraph.springernature.com/pub.10.1007/bf01740907

0 references

Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients.

1 reference

https://api.crossref.org/works/10.1007%2FBF01740907

21 January 2018

Tumour necrosis factor in man: clinical and biological observations

1 reference

https://api.crossref.org/works/10.1007%2FBF01740907

21 January 2018

Antitumor activity of recombinant interleukin 6 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of recombinant tumor necrosis factor in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody: abrogation of specific transplantation resistance to chemical carcinogen-induced syngeneic tumors by selectiv

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1: biology, pathophysiology, and clinical prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of intratumoral application of recombinant human tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences among primates in defence against infection: sensitivity of polymorphonuclear leukocytes to fMet-Leu-Phe.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I clinical trial of recombinant human tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of interleukin 6 in fever in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purification and partial primary sequence of a chemotactic protein for polymorphonuclear leukocytes derived from human lung giant cell carcinoma LU65C cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human glioblastoma cells release interleukin 6 in vivo and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of neutrophil migration by tumor necrosis factor. Ex vivo and in vivo studies in comparison with in vitro effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of interferon-gamma and tumor necrosis factor-alpha on clonogenic growth of cell lines and primary cultures from human gliomas and brain metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple biological activities of human recombinant interleukin 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of recombinant human tumor necrosis factor-alpha on the surface phenotype and the growth of human malignant glioma cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by IL-1 and IFN-gamma is inhibited by selective depletion of neutrophils with a monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor: an update on basic research and clinical applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of recombinant tumor necrosis factor (rHuTNF alpha) on human neutrophils and monocytes: in vitro, ex vivo and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/7679950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01740907

1 reference

Europe PubMed Central

1 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42482850&oldid=1959052219"